Neurology

A multidisciplinary group of investigators from Vanderbilt University Medical Center, Vanderbilt University, and the University of Pennsylvania received a $3.2 million grant to develop novel brain network-based measures to guide surgical decisions and improve outcomes in the field of epilepsy surgery. Read More

Experts in research on Alzheimer’s disease and related dementias share their latest findings at the 2023 Alzheimer’s Association International Conference. Nik Lampe, postdoctoral researcher, was awarded a grant to examine the social and medical factors influencing ADRD using data from VUSNAPS. Read More

The Department of Pharmacology's 2023 Elaine Sanders-Bush Lecture will feature Dr. Marsel Mesulam of Northwestern University; the "Temporal Pole of the Human Brain" lecture will be at 4 p.m. on May 2.  Read More

Researchers in the Vanderbilt University School of Medicine have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues. Read More

Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer’s disease. Read More

Join Hassane Mchaourab, the Louise B. McGavock Professor and professor of molecular physiology and biophysics, as he explores biomedical ethics with leading experts in law, biomedical research and basic sciences on Thursday, Sept. 29, from 11 a.m. to noon. Read More

Reported June 13 in Neurology, an Alzheimer’s disease risk study from Vanderbilt University Medical Center measures significantly reduced risk associated with healthy lifestyles, including non-smoking, leisure-time exercise, low-to-moderate alcohol consumption, adequate sleep and healthy diet. Read More

A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents. Read More

Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may… Read More

Researchers believe they can address problems stemming from heart rate, respiration and digestion by untangling which nerves control which bodily functions and then stimulating them with light. Read More

A drug commonly prescribed for Crohn’s disease and rheumatoid arthritis is also effective for treating neurosarcoidosis, according to new research led by Vanderbilt neurologists. Read More

Research by a team of Vanderbilt University Medical Center (VUMC) scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer’s pathology first begins. Read More

Vanderbilt researchers have established a new measure of resilience to cognitive impairment in people with asymptomatic Alzheimer’s disease. Read More

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3. Read More

“Neuro-diverse: A Symposium on Autism, Neuroscience and Perceptual Thinking” and an associated evening lecture – both free and open to the public – will take place on the Vanderbilt campus Monday, May 23. Read More

Vanderbilt University Medical Center has launched specialized Physical Therapy (PT) residency programs in Orthopaedics (Sports) and Pediatrics in addition to an existing Neurological program, making Vanderbilt one of a handful of hospital systems in the country to offer three or more physical therapy residencies. Read More

The extraordinary achievements of nine Vanderbilt endowed chair holders were lauded at a Sept. 8 celebration during which generous donors were thanked. Read More

Researchers at Vanderbilt University for the first time have demonstrated in a mouse model that aggregation, the “clumping together” of abnormal proteins, can contribute to a severe form of genetic epilepsy. Read More

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features. Read More

A genetic predisposition to Parkinson’s disease makes neurons more vulnerable to the toxicity of heavy metals such as copper. Read More